BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 28155639)

  • 1. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repositioning based on individual bi-random walks on a heterogeneous network.
    Wang Y; Guo M; Ren Y; Jia L; Yu G
    BMC Bioinformatics; 2019 Dec; 20(Suppl 15):547. PubMed ID: 31874623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BiRWDDA: A Novel Drug Repositioning Method Based on Multisimilarity Fusion.
    Yan CK; Wang WX; Zhang G; Wang JL; Patel A
    J Comput Biol; 2019 Nov; 26(11):1230-1242. PubMed ID: 31140857
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-target interaction prediction by random walk on the heterogeneous network.
    Chen X; Liu MX; Yan GY
    Mol Biosyst; 2012 Jul; 8(7):1970-8. PubMed ID: 22538619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNet-DNN: Inferring New Drug-Disease Associations with Deep Neural Network Based on Heterogeneous Network Features.
    Liu H; Zhang W; Song Y; Deng L; Zhou S
    J Chem Inf Model; 2020 Apr; 60(4):2367-2376. PubMed ID: 32118415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEDD: a network embedding based method for predicting drug-disease associations.
    Zhou R; Lu Z; Luo H; Xiang J; Zeng M; Li M
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):387. PubMed ID: 32938396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Drug Repositioning Approach Based on Integrative Multiple Similarity Measures.
    Yan C; Feng L; Wang W; Wang J; Zhang G; Luo J
    Curr Mol Med; 2020; 20(6):442-451. PubMed ID: 31729291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREDICT: a method for inferring novel drug indications with application to personalized medicine.
    Gottlieb A; Stein GY; Ruppin E; Sharan R
    Mol Syst Biol; 2011 Jun; 7():496. PubMed ID: 21654673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlap matrix completion for predicting drug-associated indications.
    Yang M; Luo H; Li Y; Wu FX; Wang J
    PLoS Comput Biol; 2019 Dec; 15(12):e1007541. PubMed ID: 31869322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel target convergence set based random walk with restart for prediction of potential LncRNA-disease associations.
    Li J; Li X; Feng X; Wang B; Zhao B; Wang L
    BMC Bioinformatics; 2019 Dec; 20(1):626. PubMed ID: 31795943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MD-Miner: a network-based approach for personalized drug repositioning.
    Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting drug-disease associations and their therapeutic function based on the drug-disease association bipartite network.
    Zhang W; Yue X; Huang F; Liu R; Chen Y; Ruan C
    Methods; 2018 Aug; 145():51-59. PubMed ID: 29879508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HINGRL: predicting drug-disease associations with graph representation learning on heterogeneous information networks.
    Zhao BW; Hu L; You ZH; Wang L; Su XR
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk.
    Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
    Yu L; Zhao J; Gao L
    Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.